Prostate artery embolization assessed in Swedish South East healthcare region

16

Oct 2019

In Sweden, the County Councils are grouped into six healthcare regions to facilitate cooperation and to maintain a high level of advanced medical care. One of them is the Regional Methods Council of South East healthcare region. This Council provides support for decision-making in the South East healthcare region and evaluates the scientific evidence for the introduction of new medical practices and devices in the South East healthcare region. Medicines are excluded from the scope of the assessment of the Council.

In September 2019, Regional Methods Council of South East healthcare region released a report for prostate artery embolization (PAE) for benign prostatic hyperplasia, which aimed to assess PAE in comparison to transurethral resection of the prostate (TURP) in terms of efficiency and cost-effectiveness. The Council came to the following conclusions:

  • The PAE could be performed in day surgery with the use of local anesthesia and anticoagulation treatment, whereas TURP requires hospitalization, spinal anesthesia and, in some cases, heparin injections for a period
  • Few cases of urinary incontinence and retrograde ejaculation have been reported after PAE
  • The need for blood transfusions is lower for PAE than TURP
  • The costs for PAE are lower than for TURP
  • The PAE is primarily relevant for the following groups of patients:
    • Elderly patients with comorbidities, when spinal or general anesthesia can not be used
    • Patients with prostate glands larger than 80 mL
  • The following disadvantages of PAE were determined:
    • The PAE is a technically demanding intervention with the use of X-rays and contrast agents
    • The risk of inadvertent embolization of adjacent arteries/organs
    • Possible injury of the femoral artery in the groin in the form of bleeding or clot formation
    • Aneurysm occurrence at the site of puncture
  • The following prerequisites for the introduction of PAE into the practice were outlined:
    • The good skills and interventions of radiologists
    • Well-established center
    • The operation should take place in cooperation with the urological department
  • The use of registries for follow-up of patients and registration of side effects is strongly recommended.

See the full information in Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more

04

Jan 2023

In the second half of December 2022, the Basque Office for Health Technology Assessment (OSTEBA) released a report aiming to evaluate mitral valve repair surgery as an alternative to mitral valve replacement.

Read more

22

Dec 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 24486 of December 7, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the surgical procedures, neurology and neurosurgery, and extracorporeal treatments areas.

Read more

21

Dec 2022

On November 25, 2022, the Treatment Council (Behandlingsråd) announced the third topic selected for major analyses (større analyser) for 2023. The selected topic is regarding the non-invasive treatment of obstructive sleep apnea.

Read more